For patients with squamous cell carcinoma and HER-2 negative adenocarcinomas, fluorouracil + cisplatin, or paclitaxel/docetaxel + cisplatin/nedaplatin were used. This evidence concerns the gene ERBB2 and squamous cell carcinoma.